Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | CETP | P11597 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.41 |
| ▸ | AGXT | P21549 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5907551 | 0.96 | TSHR (0.59) | TSHRCETPALDH1A1ELANESRC | |
| SCHEMBL9051015 | 0.89 | TSHR (0.52) | TSHRCETPALDH1A1ELANESRC | |
| SCHEMBL8519323 | 0.87 | TSHR (0.50) | TSHRCETPELANESRC | |
| SCHEMBL206609 | 0.87 | TSHR (0.68) | TSHRCETPALDH1A1ELANESRC | |
| SCHEMBL4586535 | 0.84 | TSHR (0.47) | TSHRCETPALDH1A1ELANEFOLH1 | |
| SCHEMBL79996 | 0.83 | TSHR (0.63) | TSHRCETPALDH1A1ELANESRC | |
| SCHEMBL8409182 | 0.82 | TSHR (0.45) | TSHRCETPALDH1A1ELANESRC | |
| SCHEMBL218693 | 0.82 | TSHR (0.57) | TSHRCETPALDH1A1ELANESRC | |
| SCHEMBL5269070 | 0.82 | TSHR (0.57) | TSHRCETPALDH1A1SRCIDO1 | |
| SCHEMBL5379773 | 0.81 | TSHR (0.61) | TSHRCETPALDH1A1ELANESRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121673323-B | Sulfide ore collecting agent based on thiophene-amide-sodium phosphate salt, and preparation method and application thereof | CHANGCHUN GOLD RESEARCH INSTITUTE Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4074719-B1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC SYNTHETIC PHARMACEUTICAL CO LTD (CN) | 2025-12-03 | — | — | EP | claimed |
| CN-120005406-A | Flame-retardant functional silicone rubber for cable accessories and preparation method thereof | 深圳市正安有机硅材料有限公司 | 2025-05-16 | — | — | CN | claimed |
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2024-12-24 | — | — | US | claimed |
| CN-119143832-A | Abiraterone acetate and preparation method thereof | 黄冈人福药业有限责任公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118165433-A | Polyvinyl chloride power pipe and preparation process thereof | 安徽海通塑胶科技有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117567455-A | Novel oxazolidinone compound and synthetic method and application thereof | 华创合成制药股份有限公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2023108296-A1 | ISOPROPYLAMINE ANALOGUES OF PHOSPHORYLATED AND SULFONATED MESCALINE DERIVATIVES | Enveric Biosciences Canada Inc. (CA) | 2023-06-22 | — | — | WO | claimed |
| WO-2023044574-A1 | PHOSPHORYLATED AND SULFONATED MESCALINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-03-30 | — | — | WO | claimed |
| US-20230046407-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2023-02-16 | — | — | US | claimed |
| WO-2017218963-A1 | COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY | ACIES BIO D.O.O. (SI) | 2017-12-21 | — | — | WO | claimed |
| EP-0998518-B1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | AMERSHAM HEALTH AS (NO) | 2003-12-10 | — | — | EP | claimed |
| US-6500917-B1 | REACTING SUCH AS POLYETHYLENE GLYCOL WITH A DIARYL- OR DIARALKYL- HALOPHOSPHATE AND REDUCTIVELY CLEAVING ARYL GROUPS; PHOSPHATE MODIFICATION WITH LOW IMPURITIES | AMERSHAM HEALTH AS (NO) | 2002-12-31 | — | — | US | claimed |
| CN-1061047-C | Process of preparing etoposide phosphate and etoposide | BRISTOL MYERS SQUIBB CO (US) | 2001-01-24 | — | — | CN | claimed |
| US-6096916-A | Synthesis of D-3 phosphorylated phosphoinositides and analogues | NUTRIMED BIOTECH (US) | 2000-08-01 | — | — | US | claimed |
| EP-0998518-A1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | NYCOMED IMAGING AS (NO) | 2000-05-10 | — | — | EP | claimed |
| WO-1999005200-A1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | NYCOMED IMAGING AS (NO) | 1999-02-04 | — | — | WO | claimed |
| CN-1189497-A | Process of preparing etoposide phosphate and etoposide | BRISTOL MYERS SQUIBB CO (US) | 1998-08-05 | — | — | CN | claimed |
| CN-1106016-A | Preparation method of etoposide phosphate and etoposide | BRISTOL MYERS SQUIBB CO (US) | 1995-08-02 | — | — | CN | claimed |
| EP-0652226-A1 | Process of preparing etoposide phosphate and etoposide | Bristol-Myers Squibb Company (US) | 1995-05-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230046407-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | CYP4F11, OXA1L, WEE2 | TSHR 3107/4885CETP 2341/4885ALDH1A1 1468/4885 |
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | CYP4F11, OXA1L, WEE2 | TSHR 3107/4885CETP 2341/4885ALDH1A1 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.